CLE
Clinical trials for CLE explained in plain language.
Never miss a new study
Get alerted when new CLE trials appear
Sign up with your email to follow new studies for CLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to tame autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new medicine, SAR448501/DR-0201, in adults with lupus or rheumatoid arthritis. The goal is to find safe and tolerable doses by checking side effects and how the drug works in the body. About 62 participants will receive multiple doses and be followe…
Matched conditions: CLE
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 08:07 UTC
-
New hope for lupus skin flares: experimental drug VENT-03 enters Mid-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called VENT-03 in 24 adults with active cutaneous lupus (skin lupus), with or without systemic lupus. Participants take VENT-03 or a placebo for 4 weeks, then everyone gets VENT-03 for 8 more weeks. The goal is to see if the drug reduces skin…
Matched conditions: CLE
Phase: PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC